To focus on older women and men with type 2 diabetes, we conducted the same univariate and multivariate sub-group analyses using the population after excluding ones with type 1 diabetes who were prescribed with insulin only or with insulin in combination with each of two SGLT2 inhibitors, ipragliflozin and dapagliflozin, applicable to type 1 diabetes. This evidence concerns the gene SLC5A2 and type 1 diabetes mellitus.